-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of the cost of borrowed funds accounted for as interest expense.
-
Summary
-
Poseida Therapeutics, Inc. quarterly/annual Interest Expense history and growth rate from Q2 2019 to Q2 2024.
- Poseida Therapeutics, Inc. Interest Expense for the quarter ending June 30, 2024 was $2.26M, a 5.51% increase year-over-year.
- Poseida Therapeutics, Inc. Interest Expense for the twelve months ending June 30, 2024 was $9.01M, a 18.1% decline year-over-year.
- Poseida Therapeutics, Inc. annual Interest Expense for 2023 was $8.67M, a 36.1% increase from 2022.
- Poseida Therapeutics, Inc. annual Interest Expense for 2022 was $6.37M, a 89.7% increase from 2021.
- Poseida Therapeutics, Inc. annual Interest Expense for 2021 was $3.36M, a 4.22% decline from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)